v3.26.1
Consolidated Balance Sheets - USD ($)
$ in Thousands
Dec. 31, 2025
Dec. 31, 2024
Current assets:    
Cash $ 3,599 $ 1,275
Accounts receivable, net of allowance of $50 and $77, respectively 3,603 1,858
Note receivable 1,400
Current licensing fees receivable 150
Inventories, net 2,657 3,364
Prefunded insurance premiums from financing 214 199
Prepaid expenses and other current assets 1,224 614
Deferred financing costs 415
Current assets of discontinued operations 1,070
Total current assets 13,262 8,380
Long-term licensing fees receivable 1,647
Fixed assets, net of accumulated depreciation of $583 and $422, respectively 321 108
Non-current assets of discontinued operations 35
Total assets 15,230 8,523
Current liabilities:    
Accounts payable 6,378 3,279
Accrued expenses 3,960 2,464
Revolving credit facility and loans 3,022 291
Insurance premium financing 214 199
Promissory notes 190
Current liabilities of discontinued operations 134
Total current liabilities 13,764 6,367
Total liabilities 13,764 6,367
Commitments and contingencies (Note 14)
Shareholders’ equity:    
Common stock, no par value: Authorized — 800,000,000 . Issued and outstanding shares — 118,227,478 shares and 115,867,659 shares, respectively 95,895 94,883
Accumulated other comprehensive income 299 222
Accumulated deficit (94,728) (92,949)
Total shareholders’ equity 1,466 2,156
Total liabilities and shareholders’ equity $ 15,230 $ 8,523